DEXCOM INC (DXCM) Fundamental Analysis & Valuation
NASDAQ:DXCM • US2521311074
Current stock price
61.57 USD
-1.13 (-1.8%)
At close:
61.57 USD
0 (0%)
After Hours:
This DXCM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. DXCM Profitability Analysis
1.1 Basic Checks
- In the past year DXCM was profitable.
- DXCM had a positive operating cash flow in the past year.
- In the past 5 years DXCM has always been profitable.
- In the past 5 years DXCM always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of DXCM (13.19%) is better than 93.58% of its industry peers.
- DXCM's Return On Equity of 30.46% is amongst the best of the industry. DXCM outperforms 96.79% of its industry peers.
- DXCM has a Return On Invested Capital of 18.92%. This is amongst the best in the industry. DXCM outperforms 96.79% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for DXCM is significantly above the industry average of 9.12%.
- The 3 year average ROIC (14.59%) for DXCM is below the current ROIC(18.92%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.19% | ||
| ROE | 30.46% | ||
| ROIC | 18.92% |
ROA(3y)10.24%
ROA(5y)8.29%
ROE(3y)28.01%
ROE(5y)22.13%
ROIC(3y)14.59%
ROIC(5y)11.66%
1.3 Margins
- DXCM's Profit Margin of 17.94% is amongst the best of the industry. DXCM outperforms 93.05% of its industry peers.
- DXCM's Profit Margin has declined in the last couple of years.
- The Operating Margin of DXCM (21.55%) is better than 94.12% of its industry peers.
- DXCM's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 62.09%, DXCM is in the better half of the industry, outperforming 64.17% of the companies in the same industry.
- DXCM's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.55% | ||
| PM (TTM) | 17.94% | ||
| GM | 62.09% |
OM growth 3Y15.68%
OM growth 5Y5.09%
PM growth 3Y15.23%
PM growth 5Y-8.86%
GM growth 3Y-1.61%
GM growth 5Y-1.72%
2. DXCM Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DXCM is creating value.
- Compared to 1 year ago, DXCM has less shares outstanding
- Compared to 5 years ago, DXCM has about the same amount of shares outstanding.
- Compared to 1 year ago, DXCM has an improved debt to assets ratio.
2.2 Solvency
- DXCM has an Altman-Z score of 6.11. This indicates that DXCM is financially healthy and has little risk of bankruptcy at the moment.
- DXCM's Altman-Z score of 6.11 is fine compared to the rest of the industry. DXCM outperforms 79.14% of its industry peers.
- DXCM has a debt to FCF ratio of 1.20. This is a very positive value and a sign of high solvency as it would only need 1.20 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 1.20, DXCM belongs to the best of the industry, outperforming 89.84% of the companies in the same industry.
- A Debt/Equity ratio of 0.47 indicates that DXCM is not too dependend on debt financing.
- With a Debt to Equity ratio value of 0.47, DXCM perfoms like the industry average, outperforming 41.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 1.2 | ||
| Altman-Z | 6.11 |
ROIC/WACC2.27
WACC8.32%
2.3 Liquidity
- DXCM has a Current Ratio of 1.88. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
- DXCM has a Current ratio of 1.88. This is in the lower half of the industry: DXCM underperforms 65.78% of its industry peers.
- DXCM has a Quick Ratio of 1.59. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
- With a Quick ratio value of 1.59, DXCM perfoms like the industry average, outperforming 41.71% of the companies in the same industry.
- DXCM does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.59 |
3. DXCM Growth Analysis
3.1 Past
- DXCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.73%, which is quite good.
- Measured over the past years, DXCM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.29% on average per year.
- The Revenue has grown by 15.60% in the past year. This is quite good.
- Measured over the past years, DXCM shows a quite strong growth in Revenue. The Revenue has been growing by 19.33% on average per year.
EPS 1Y (TTM)12.73%
EPS 3Y28.82%
EPS 5Y19.29%
EPS Q2Q%0%
Revenue 1Y (TTM)15.6%
Revenue growth 3Y17.01%
Revenue growth 5Y19.33%
Sales Q2Q%13.12%
3.2 Future
- DXCM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.44% yearly.
- DXCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.44% yearly.
EPS Next Y36.73%
EPS Next 2Y27.84%
EPS Next 3Y25.1%
EPS Next 5Y22.44%
Revenue Next Year12.62%
Revenue Next 2Y12.47%
Revenue Next 3Y12.38%
Revenue Next 5Y12.44%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. DXCM Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 33.10, the valuation of DXCM can be described as expensive.
- Based on the Price/Earnings ratio, DXCM is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
- DXCM's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.42.
- The Price/Forward Earnings ratio is 24.21, which indicates a rather expensive current valuation of DXCM.
- Based on the Price/Forward Earnings ratio, DXCM is valued a bit cheaper than the industry average as 75.40% of the companies are valued more expensively.
- DXCM is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.24, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.1 | ||
| Fwd PE | 24.21 |
4.2 Price Multiples
- 75.94% of the companies in the same industry are more expensive than DXCM, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of DXCM indicates a rather cheap valuation: DXCM is cheaper than 86.63% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22 | ||
| EV/EBITDA | 17.44 |
4.3 Compensation for Growth
- DXCM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- DXCM has an outstanding profitability rating, which may justify a higher PE ratio.
- DXCM's earnings are expected to grow with 25.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.9
PEG (5Y)1.72
EPS Next 2Y27.84%
EPS Next 3Y25.1%
5. DXCM Dividend Analysis
5.1 Amount
- DXCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
DXCM Fundamentals: All Metrics, Ratios and Statistics
61.57
-1.13 (-1.8%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12 2026-02-12/amc
Earnings (Next)04-30 2026-04-30/amc
Inst Owners101.29%
Inst Owner Change0.66%
Ins Owners0.25%
Ins Owner Change9.15%
Market Cap23.70B
Revenue(TTM)4.66B
Net Income(TTM)836.30M
Analysts84.86
Price Target89.4 (45.2%)
Short Float %3.84%
Short Ratio3.35
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.4%
Min EPS beat(2)-32.12%
Max EPS beat(2)5.32%
EPS beat(4)2
Avg EPS beat(4)-6.03%
Min EPS beat(4)-32.12%
Max EPS beat(4)6.77%
EPS beat(8)5
Avg EPS beat(8)-1.11%
EPS beat(12)9
Avg EPS beat(12)9.15%
EPS beat(16)11
Avg EPS beat(16)5.86%
Revenue beat(2)1
Avg Revenue beat(2)-0.14%
Min Revenue beat(2)-0.9%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-0.9%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-1.02%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)6
Avg Revenue beat(16)-0.53%
PT rev (1m)1.2%
PT rev (3m)2.02%
EPS NQ rev (1m)0.17%
EPS NQ rev (3m)-0.25%
EPS NY rev (1m)0.03%
EPS NY rev (3m)1.03%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-0.42%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.1 | ||
| Fwd PE | 24.21 | ||
| P/S | 5.08 | ||
| P/FCF | 22 | ||
| P/OCF | 16.45 | ||
| P/B | 8.63 | ||
| P/tB | 8.94 | ||
| EV/EBITDA | 17.44 |
EPS(TTM)1.86
EY3.02%
EPS(NY)2.54
Fwd EY4.13%
FCF(TTM)2.8
FCFY4.55%
OCF(TTM)3.74
OCFY6.08%
SpS12.11
BVpS7.14
TBVpS6.89
PEG (NY)0.9
PEG (5Y)1.72
Graham Number17.2801 (-71.93%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.19% | ||
| ROE | 30.46% | ||
| ROCE | 23.93% | ||
| ROIC | 18.92% | ||
| ROICexc | 36.12% | ||
| ROICexgc | 37.75% | ||
| OM | 21.55% | ||
| PM (TTM) | 17.94% | ||
| GM | 62.09% | ||
| FCFM | 23.11% |
ROA(3y)10.24%
ROA(5y)8.29%
ROE(3y)28.01%
ROE(5y)22.13%
ROIC(3y)14.59%
ROIC(5y)11.66%
ROICexc(3y)37.89%
ROICexc(5y)31.72%
ROICexgc(3y)41.79%
ROICexgc(5y)35.48%
ROCE(3y)18.46%
ROCE(5y)14.75%
ROICexgc growth 3Y1.89%
ROICexgc growth 5Y6.96%
ROICexc growth 3Y7.33%
ROICexc growth 5Y6.44%
OM growth 3Y15.68%
OM growth 5Y5.09%
PM growth 3Y15.23%
PM growth 5Y-8.86%
GM growth 3Y-1.61%
GM growth 5Y-1.72%
F-Score8
Asset Turnover0.74
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 1.2 | ||
| Debt/EBITDA | 1.03 | ||
| Cap/Depr | 144.36% | ||
| Cap/Sales | 7.8% | ||
| Interest Coverage | 88.12 | ||
| Cash Conversion | 114.67% | ||
| Profit Quality | 128.81% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.59 | ||
| Altman-Z | 6.11 |
F-Score8
WACC8.32%
ROIC/WACC2.27
Cap/Depr(3y)145.46%
Cap/Depr(5y)210.39%
Cap/Sales(3y)7.74%
Cap/Sales(5y)10.33%
Profit Quality(3y)110.93%
Profit Quality(5y)89.33%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y28.82%
EPS 5Y19.29%
EPS Q2Q%0%
EPS Next Y36.73%
EPS Next 2Y27.84%
EPS Next 3Y25.1%
EPS Next 5Y22.44%
Revenue 1Y (TTM)15.6%
Revenue growth 3Y17.01%
Revenue growth 5Y19.33%
Sales Q2Q%13.12%
Revenue Next Year12.62%
Revenue Next 2Y12.47%
Revenue Next 3Y12.38%
Revenue Next 5Y12.44%
EBIT growth 1Y53.73%
EBIT growth 3Y35.36%
EBIT growth 5Y25.41%
EBIT Next Year67.73%
EBIT Next 3Y32.66%
EBIT Next 5Y25.77%
FCF growth 1Y70.79%
FCF growth 3Y52.34%
FCF growth 5Y31.25%
OCF growth 1Y45.6%
OCF growth 3Y29.1%
OCF growth 5Y24.81%
DEXCOM INC / DXCM Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for DEXCOM INC?
ChartMill assigns a fundamental rating of 7 / 10 to DXCM.
What is the valuation status of DEXCOM INC (DXCM) stock?
ChartMill assigns a valuation rating of 6 / 10 to DEXCOM INC (DXCM). This can be considered as Fairly Valued.
What is the profitability of DXCM stock?
DEXCOM INC (DXCM) has a profitability rating of 8 / 10.
How financially healthy is DEXCOM INC?
The financial health rating of DEXCOM INC (DXCM) is 8 / 10.